Previous Article | Next Article 
Journal of Virology, August 2003, p. 8555-8561, Vol. 77, No. 15
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.15.8555-8561.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Length of Epstein-Barr Virus Termini as a Determinant of Epithelial Cell Clonal Emergence
Cary A. Moody,1 Rona S. Scott,1 Tao Su,1 and John W. Sixbey1,2*
Department of Microbiology and Immunology,1
Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center, Shreveport, Louisiana2
Received 16 December 2002/
Accepted 3 May 2003
Reiterated terminal sequences of Epstein-Barr virus (EBV) DNA are numerically heterogeneous among infectious virions, providing a viral measure of clonality in infected cells. After in vitro infection, carcinoma cells bearing EBV episomes with fewer terminal repeats (TRs) proliferated faster. In single-cell clones, TR number varied inversely to the quantity of latent membrane protein 2A (LMP2A) transcripts whose unspliced precursors cross joined TRs. Thus, EBV clonality may reflect selection for a TR number that optimizes LMP2A-enhanced tumor progression, with infection occurring after epithelial cell transformation.
* Corresponding author. Mailing address: Department of Microbiology and Immunology, Louisiana State University Health Sciences Center, 1501 Kings Highway, Shreveport, LA 71130. Phone: (318) 675-4272. Fax: (318) 675-5764. E-mail:
jsixbe{at}lsuhsc.edu.
Journal of Virology, August 2003, p. 8555-8561, Vol. 77, No. 15
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.15.8555-8561.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Faumont, N., Chanut, A., Benard, A., Cogne, N., Delsol, G., Feuillard, J., Meggetto, F.
(2009). Comparative analysis of oncogenic properties and nuclear factor-{kappa}B activity of latent membrane protein 1 natural variants from Hodgkin's lymphoma's Reed-Sternberg cells and normal B-lymphocytes. haematol
94: 355-363
[Abstract]
[Full Text]
-
Fukuda, M., Longnecker, R.
(2007). Epstein-Barr Virus Latent Membrane Protein 2A Mediates Transformation through Constitutive Activation of the Ras/PI3-K/Akt Pathway. J. Virol.
81: 9299-9306
[Abstract]
[Full Text]
-
Turk, S. M., Jiang, R., Chesnokova, L. S., Hutt-Fletcher, L. M.
(2006). Antibodies to gp350/220 Enhance the Ability of Epstein-Barr Virus To Infect Epithelial Cells. J. Virol.
80: 9628-9633
[Abstract]
[Full Text]
-
Moody, C. A., Scott, R. S., Amirghahari, N., Nathan, C.-A., Young, L. S., Dawson, C. W., Sixbey, J. W.
(2005). Modulation of the Cell Growth Regulator mTOR by Epstein-Barr Virus-Encoded LMP2A. J. Virol.
79: 5499-5506
[Abstract]
[Full Text]
-
Stewart, S., Dawson, C. W., Takada, K., Curnow, J., Moody, C. A., Sixbey, J. W., Young, L. S.
(2004). Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-{kappa}B transcription factor pathway. Proc. Natl. Acad. Sci. USA
101: 15730-15735
[Abstract]
[Full Text]
-
Fukuda, M., Longnecker, R.
(2004). Latent Membrane Protein 2A Inhibits Transforming Growth Factor-{beta}1-Induced Apoptosis through the Phosphatidylinositol 3-Kinase/Akt Pathway. J. Virol.
78: 1697-1705
[Abstract]
[Full Text]